Agenus
AGEN
#9101
Rank
NZ$0.20 B
Marketcap
NZ$5.96
Share price
-1.99%
Change (1 day)
23.83%
Change (1 year)

Earnings for Agenus (AGEN)

Earnings in 2025 (TTM): NZ$35.28 Million

According to Agenus 's latest financial reports the company's current earnings are NZ$0.10 Billion. In 2024 the company made an earning of -NZ$0.2 Billion, an increase over its 2023 earnings that were of -NZ$0.28 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agenus from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$35.28 M-117.77%
2024 -NZ$0.2 Billion-28.13%
2023 -NZ$0.28 Billion-5.5%
2022 -NZ$0.3 Billion-556.26%
2021 NZ$64.09 M-130.37%
2020 -NZ$0.22 Billion73.75%
2019 -NZ$0.13 Billion-48.74%
2018 -NZ$0.24 Billion34.32%
2017 -NZ$0.18 Billion-7.16%
2016 -NZ$0.2 Billion26.55%
2015 -NZ$0.16 Billion110.24%
2014 -NZ$71.43 Million49.12%
2013 -NZ$47.9 Million
2011 -NZ$33.07 Million-12.25%
2010 -NZ$37.69 Million-21.41%
2009 -NZ$47.96 Million-26.86%
2008 -NZ$65.57 Million13.72%
2007 -NZ$57.66 Million-33.4%
2006 -NZ$86.57 Million-31.84%
2005 -NZ$0.13 Billion9.74%
2004 -NZ$0.12 Billion-0.8%
2003 -NZ$0.12 Billion17.37%
2002 -NZ$99.41 Million37.83%
2001 -NZ$72.12 Million55.99%
2000 -NZ$46.24 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Merck
MRK
NZ$40.00 B 111,645.63%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$16.15 B 45,018.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
NZ$56.12 B 156,682.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.45 Billion-1,340.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$13.91 B 38,776.25%๐Ÿ‡บ๐Ÿ‡ธ USA